[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
August 25, 2010

FDA Approves Generic Enoxaparin

JAMA. 2010;304(8):844. doi:10.1001/jama.2010.1195

The US Food and Drug Administration (FDA) has approved the first generic version of enoxaparin sodium injection, an anticoagulant used to prevent potentially fatal deep vein thrombosis.

Injectable enoxaparin often is used to prevent blood clots in patients who have had knee or hip replacement or, in some cases, abdominal surgery. Enoxaparin is in the low-molecular-weight heparin class of drugs and is used differently than heparin even though both are anticoagulants.

First Page Preview View Large
First page PDF preview
First page PDF preview